Resources
Analytic Recipes #5
The Interplay of Musculoskeletal Disorders and Mental Health: Analyzing Costs and Prevalence in Employer Populations
September 3, 2024, 12:00 ET
Health Analytic Connect Launches Analytic Recipe #5: Exploring the Interplay of Musculoskeletal Disorders and Mental Health
Health Analytic Connect is proud to introduce Analytic Recipe #5, focusing on the critical connection between Musculoskeletal (MSK) disorders and mental health. This latest release dives deep into the intricate relationship between chronic MSK conditions and mental health, shedding light on how these intertwined issues drive healthcare costs and impact patient outcomes. By leveraging advanced data analytics, Analytic Recipe #5 offers actionable insights for employers and health plans, helping them better understand the financial and clinical implications of these comorbidities. This comprehensive analysis equips organizations with the tools to identify cost-saving opportunities and implement targeted interventions, reinforcing our commitment to delivering data-driven solutions that support informed decision-making and improved health outcomes.
Click here to view the complete study.
Author(s):
Mary Henderson, PhD, Principal & Co-Founder
Denise Zeman, Principal & Co-Founder
Jon Rimbach, Principal & Co-Founder
For more information on Health Analytics Connect, visit the Health Analytics Connect website at https://www.healthanalyticsconnect.com.
For business or media inquiries, please get in touch with us at [email protected]
SOURCE Health Analytics Connect, LLC
Analytic Recipes #4
Harnessing Data Analytics to Combat PAD
April 2024, 12:00 ET
Peripheral Artery Disease (PAD) affects 7% of the U.S. population, driven by rising diabetes, obesity, and hypertension rates. PAD leads to severe health consequences, including amputation and higher mortality rates. The condition is costly, particularly for patients with multiple chronic conditions, with healthcare expenses five times higher than for those with PAD alone. Effective management requires early diagnosis and comprehensive treatment. Strategic data analytics can improve PAD care by identifying risks, optimizing resource use, and personalizing interventions. A collaborative, data-driven approach can enhance patient outcomes and reduce healthcare costs.
Click here to view the complete study.
Author(s):
Denise Zeman, Principal & Co-Founder
Mary Henderson, PhD, Principal & Co-Founder
Jon Rimbach, Principal & Co-Founder
For more information on Health Analytics Connect, visit the Health Analytics Connect website at https://www.healthanalyticsconnect.com.
For business or media inquiries, please get in touch with us at [email protected]
SOURCE Health Analytics Connect, LLC
Analytic Recipes #3
Unmasking the Vape Cloud: Navigating the Impact
of Vaping on Employers, Health Insurance, and Data Analytics
December 5, 2023, 12:00 ET
Explore the critical findings of 'Unmasking the Vape Cloud,' a study diving into the multifaceted impact of vaping on employer-sponsored health plans, financial burdens, and health risks. Discover how increased healthcare costs, workplace productivity challenges, and underreporting in insurance claims are reshaping how employers address vaping. Learn about the vital role of data analytics in navigating these challenges and the importance of targeted health initiatives.
Click here to view the complete study.
Author(s):
Denise Zeman, Principal & Co-Founder
Kevin O'Mara, Principal & Co-Founder
Joulan Wu, Principal & Co-Founder
For more information on Health Analytics Connect, visit the Health Analytics Connect website at https://www.healthanalyticsconnect.com.
For business or media inquiries, please get in touch with us at [email protected]
SOURCE Health Analytics Connect, LLC
Analytic Recipes #2:
Childhood Obesity in the United States:
A Complex Challenge Requiring Multifaceted Solutions
October 19, 2023, 12:00 ET
Childhood obesity has emerged as a critical public health concern in the United States, affecting millions of children and posing severe health risks. Alarming statistics from the Centers for Disease Control and Prevention (CDC) reveal a distressing threefold increase in childhood obesity rates over the past three decades, and this upward trend shows no signs of slowing down. Currently, over 20% of children between the ages of 2 and 19 grapple with the challenges of obesity, but the prevalence is not uniform. It varies dramatically across racial, ethnic, and socioeconomic lines, making it a complex issue that demands multifaceted solutions.
Click here to view the mini white paper.
Author(s):
Kevin O’Mara, Principal & Co-Founder, Health Analytics Connect
Mary Henderson, PhD, Principal & Co-Founder, Health Analytics Connect
Denise Zeman, Principal & Co-Founder, Health Analytics Connect
For more information on Health Analytics Connect, visit the Health Analytics Connect website at https://www.healthanalyticsconnect.com.
For business or media inquiries, please contact us at [email protected]
SOURCE Health Analytics Connect, LLC
Analytic Recipes #1
Analysis of Rising Pharmacy Costs and Trends in GLP-1/SGLT-2 Drug Utilization
September 22, 2023, 12:00 ET
This research report investigates the escalating pharmacy costs within the healthcare industry, focusing on the substantial increase in allowed pharmacy per member per month (PMPM) expenditures associated with GLP-1 and SGLT-2 drugs. These medications, initially designed for diabetes management, are now gaining popularity as practical tools for weight loss. Our study reveals a 16% rise in allowed pharmacy PMPM over the last two study periods, with GLP-1 and SGLT-2 drugs responsible for more than 40% of the net overall pharmacy trend. This report examines these drugs' demographic and usage patterns within different cohorts and sub-cohorts, highlighting the potential implications for healthcare costs and patient care.
Click here to view the report.
Author(s):
Scott Guichard, Principal & Co-Founder
Mary Henderson, PhD, Principal & Co-Founder
Joulan Wu, Principal & Co-Founder
Denise Zeman, Principal & Co-Founder
For more information on Health Analytics Connect, visit the Health Analytics Connect website at https://www.healthanalyticsconnect.com.
For business or media inquiries, please get in touch with us at [email protected]
SOURCE Health Analytics Connect, LLC
The Hollywood Diet
August 4, 2023, 12:00 ET
The latest craze in the world of weight loss gimmicks may not be a gimmick at all. The hottest topic in healthcare these days seems to be the emergence of effective drugs that facilitate significant weight loss.
Health Analytic Connect’s research has shown that the cost and use of these treatments have increased exponentially over the past two years. In fact, we found that those diagnosed as overweight or obese (but not diabetic) exhibited nearly an 800% increase in spending for these drugs and grew the number of claimants by more than 900%.
Originally developed for diabetes patients to help with blood sugar control, these drugs were soon found to be also effective for weight loss. Ozempic is the most recognizable brand name, but there are a number of similar drugs. These are technically referred to as glucagon-like peptide (GLP-1) agonists or sodium-glucose cotransporter 2 (SGLT-2) inhibitors. In layman’s terms, these drugs affect hormones regulating appetite which results in reduced feelings of hunger with few other lifestyle changes.
The emergence of these drugs has led to an explosion in consumer demand as another option for weight management – for both people with diabetes and other weight-related health conditions, but also those just wanting to quickly lose a few pounds. Their popularity has caused nationwide shortages of some of these drugs, potentially jeopardizing the health of those patients with serious health conditions.
These drugs are extremely expensive – often costing more than $1,000 a month – and are often prescribed indefinitely once patients initiate treatment. This results in millions in additional expenses for health benefits.
To provide perspective, retail drug prescriptions are already a leading driver of the overall trend in medical costs. Research indicates that for a commercial population, pharmacy costs have grown nearly 16% over a two-year period, compared to 10% for overall medical costs.
However, by isolating the GLP-1 and SGLT-2 drug trends, a new story emerges. Costs for these drugs have increased more than 80% over the last two years and account for almost half of the pharmacy trend. Direct-to-consumer advertising has contributed to the exponential growth, and the reality of huge untapped demand will ensure the momentum will continue to grow.
Notably, our research shows that only 11% of the overweight/obese population and 28% of the diabetic population are currently taking these drugs, leaving significant room for expansion.
We can help!
An important first step is to understand what your data is telling you. For example, analyzing these trends provides insights for action. HAC Analytic Recipes℠ provide a framework for this type of analysis. Our guidelines and templates can be customized to fit your unique data needs.
HAC Analytic Recipes℠ can help you:
· Understand your actual spend on GLP-1/SGLT-2 drugs.
· Isolate the impact these drugs are having on pharmacy and overall trends.
· Compare your experience to benchmarks.
· Evaluate the health and demographic characteristics of those taking these drugs.
· Measure the effectiveness of programs implemented to manage the appropriate use of these medications.
Contact us now at [email protected] for more information about how HAC Analytic Recipes℠ can help you quickly and accurately answer the above questions and more for your population.
Author(s):
Scott Guichard, Principal & Co-Founder
Mary Henderson, Ph.D., Principal & Co-Founder
Denise Zeman, Principal & Co-Founder
For more information on Health Analytics Connect, visit the Health Analytics Connect website at https://www.healthanalyticsconnect.com.
For business or media inquiries, please contact us at [email protected]
SOURCE Health Analytics Connect, LLC
NEWS PROVIDED BY
June 26, 2023, 12:00 ET
CHICAGO, June 26, 2023 -- Health Analytics Connect (HAC) is pleased to announce that Mary Henderson has joined the Health Care Cost Institute’s Governing Board. Mary is thrilled to join the HCCI’s distinguished Governing Board as their newest member. As a new board member, Mary brings more than 30 years of experience in designing and implementing business intelligence products in the healthcare reporting and analytics industry. She has conducted analyses of cost, utilization, and quality of healthcare benefits and health management programs for many top U.S. employers, leading health plans, and large provider organizations. Mary is excited to contribute her expertise and to collaborate with the Governing Board to strengthen HCCI’s company's position further and drive its growth and success.
Mary was the President of the CVS/Aetna-owned subsidiary Health Data Management Solutions (HDMS), where HDMS provided leading-edge healthcare analytics solutions and consulting to large employers, payers, and provider systems, including international engagements. She then served as Senior Vice President of Business Solutions at the American Medical Association. Her responsibilities included overseeing the CPT licensing business, the Provider credentialing products, and the data management and licensing for the Physician Master File, the most comprehensive database on physicians and other health professionals in the US.
Mary’s most recent position was with Blue Health Intelligence (BHI), a Blues-owned company specializing in advanced data analytics and solutions empowered by the country's largest commercial claims database. She served as Executive Vice President and oversaw all sales of products and services, account management, and product development.
Mary has a PhD from Brandeis University, focusing on health economics, and a BA in psychology from Temple University, graduating summa cum laude.
For more information on the Health Care Cost Institute (HCCI), visit the HCCI website at www.healthcostinstitute.org. For business or media inquiries, please get in touch with HCCI at [email protected]
For more information on Health Analytics Connect, visit the Health Analytics Connect website at https://www.healthanalyticsconnect.com.
For business or media inquiries, please get in touch with us at [email protected]
SOURCE Health Analytics Connect, LLC
NEWS PROVIDED BY
July 12, 2022, 12:00 ET
CHICAGO, July 12, 2022 -- Health Analytics Connect (HAC) is excited to announce the launch of a new health analytics consulting firm. Health Analytics Connect was born from our decades of experience across an array of established and start-up healthcare organizations, employer groups and data warehouses, as well as a growing recognition of the real need for a fully comprehensive set of solutions to facilitate success across the board.
“There has been tremendous growth in health tech start-ups and digital health solutions in recent years and while each of those offerings may be different, we see very common stumbling blocks across this industry” comments Mary Henderson, Principal at HAC, “We wanted to provide a service to help guide companies through these obstacles to a path of success.”
HAC offers a fully comprehensive set of solutions to organize and manage healthcare data in all its forms along with developing an effective long-term data and analytics strategy. These wrap-around services enable the ability to harness the full value from the wealth of data generated. We guide you through these difficult processes and seamlessly bring together disparate data types to allow you to more efficiently grow your business, measure clinical and financial outcomes, as well as to derive meaningful and actionable insights that will ultimately improve your ability to serve customers.
For more information on Health Analytics Connect, visit the Health Analytics Connect website at: https://www.healthanalyticsconnect.com.
For business or media inquiries, please contact us at [email protected]
SOURCE Health Analytics Connect, LLC